Tyligand Bioscience
PrivateLast Round
IPO
Jan 29, 2026
Est. Valuation
$222.2M
Total Funding Raised
$74.61M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of innovative small molecule therapeutics and antibody-drug conjugates for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tyligand Bioscience Comparables
Compare Tyligand Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kumquat Biosciences | 83% | |
| BridgeBio Oncology | 83% | |
| Jacobio Pharmaceuticals Group Co Ltd | 81% |
Tyligand Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jan 29, 2026 | ||||
| Series B | Apr 1, 2024 | ||||
| Series A Extension | Nov 1, 2022 | ||||
| Series A | Apr 1, 2021 | ||||
| Pre Seed | Sep 1, 2018 |
Tyligand Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ming Bioventures | Series A Extension |
| Medfine Capital | Pre Seed |
| Yijing Capital | Series A |
| 险峰K2VC | Pre Seed |
| Lilly Asia Ventures | Series B |
| Hongli Innovation Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 29, 2026
Completed IPO at $275M pre-money valuation.
- Apr 1, 2024
$27M round led by Lilly Asia Ventures.
Tyligand Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tyligand Bioscience's valuation, stock price, and market status.
Is Tyligand Bioscience a public or private company?
Tyligand Bioscience is a private company.
What is the current stock price of Tyligand Bioscience?
Tyligand Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is Tyligand Bioscience worth (valuation)?
Tyligand Bioscience's valuation is estimated at $222.2M based on funding round data.
Can I buy Tyligand Bioscience stock?
Tyligand Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tyligand Bioscience's last funding round?
Tyligand Bioscience's most recent funding round was IPO on April 1, 2024.
Who are the main investors in Tyligand Bioscience?
Key investors in Tyligand Bioscience include Ming Bioventures.
Will Tyligand Bioscience IPO soon?
No public IPO plans have been announced for Tyligand Bioscience.
How can I track Tyligand Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tyligand Bioscience's secondary market activity and sign up for updates.